Key result
Higher baseline METS-VF is linked to ~113% greater risk of prediabetes progressing to diabetes.
Why the study?
METS-VF is an effective indicator of visceral adipose tissue, but its association with prediabetes development in middle-aged and elderly adults in China needed exploration.
Does a higher Metabolic Score for Visceral Fat (METS-VF) predict progression to diabetes or regression to normoglycemia in middle-aged and elderly adults with prediabetes?
Cohort (n=2,143)
Yes
Does a higher Metabolic Score for Visceral Fat (METS-VF) predict progression to diabetes or regression to normoglycemia in middle-aged and elderly adults with prediabetes?
Higher Metabolic Score for Visceral Fat (METS-VF) is significantly associated with an increased risk of progression to diabetes and a reduced likelihood of regression to normoglycemia in Chinese adults with prediabetes.
METS-VF may aid progression risk stratification in prediabetes; leaves open validation beyond this Chinese cohort and causal effects.
Introduction and Objective: The Metabolic Score for Visceral Fat (METS-VF) is an effective indicator of visceral adipose tissue (VAT). This study aimed to explore the association between METS-VF and prediabetes development in middle-aged and elderly adults in China. Methods: This study used data from the China Health and Retirement Longitudinal Study (CHARLS) 2011 (baseline) and 2015 (endpoint) waves. The associations between baseline METS-VF, cumulative METS-VF (cumMETS-VF), METS-VF changes and prediabetes development (progression to diabetes or regression to normoglycemia) were explored using Cox regression and restricted cubic spline (RCS) models. Subgroup analyses and interaction tests were also conducted. Results: A total of 2,143 participants with prediabetes at baseline were enrolled. Over 3 years follow-up, 12.93% progressed to diabetes, while 23.28% regressed to normoglycemia. Baseline METS-VF and cumMETS-VF were positively associated with prediabetes progression [HRs (95% CIs) 2.126 (1.576-2.868), 1.351 (1.215-1.503)], and negatively associated with regression to normoglycemia [HRs (95% CIs) 0.757 (0.637-0.899), 0.902 (0.849-0.959)]. Additionally, compared to individuals with consistently-low METS-VF, those with low-to-high and consistently-high METS-VF had a 63.4% and 141.2% higher risk of prediabetes progression. In contrast, the probability of regression to normoglycemia decreased by 23.4% in the consistently-high group. Moreover, RCS analysis demonstrated a nonlinear relationship between cumMETS-VF and prediabetes progression. Among individuals with BMI>24kg/m², higher baseline METS-VF was significantly associated with a reduced likelihood of prediabetes regression (P interaction<0.05). Conclusion: METS-VF is correlated with the prediabetes development among middle-aged and elderly adults in China. High METS-VF significantly increased the risk of progression to diabetes and hindered the regression to normolycemia.
No takes yet. Share an insight, caveat, or question.
DU et al. (2026) conducted a cohort in prediabetes (n=2,143). Metabolic Score for Visceral Fat (METS-VF) vs. Lower METS-VF was evaluated on prediabetes progression to diabetes (HR 2.126, 95% CI 1.576-2.868). Higher baseline Metabolic Score for Visceral Fat (METS-VF) was significantly associated with an increased risk of progression from prediabetes to diabetes (HR 2.126; 95% CI 1.576-2.868).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: